The Impact of Intralesional Interferon α–2b Injection Therapy on Penile Hemodynamics in Men with Peyronie’s Disease
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Introduction: Penile duplex Doppler ultrasound (PDDU) is currently the preferred method for the functional evaluation of penile hemodynamics. PDDU may be used to monitor objectively changes in penile vascular parameters in men who undergo treatment for Peyronie’s disease (PD), including intralesional interferon alpha–2b (IFN α–2b). Aim: To investigate the impact of intralesional IFN α–2b therapy for PD on penile hemodynamics by using PDDU and to assess the objective role of PDDU in monitoring treatment outcomes. Materials and Methods: Thirty–nine patients (20 in the placebo and 19 in the IFN α–2b treatment arm) were enrolled in this prospective, placebo–controlled, parallel study. Patients received either 10 mL saline or 5 × 106 units of IFN α–2b intralesional injections every other week for a total of six injections. Patients in each group were evaluated at baseline and after completion of treatment regarding changes in penile hemodynamic parameters, penile curvature, plaque size and density, pain on erection, and erectile function. Specific published criteria were used for PDDU measurements. Outcomes were statistically compared between each group by using Mann–Whitney U and chi–square tests. Results: The mean age of the patients and the duration of PD were similar in both groups. The improvement in penile blood flow was significantly greater in IFN α–2b–treated patients than those in the placebo group. The number with the nonvascular classification increased significantly in the IFN α–2b arm from 31.5% to 57.8%. Additionally, improvements in penile curvature, plaque size and density, and pain on erection were better in the IFN α–2b group compared with the control. No significant improvement was observed in the erectile function domain in either group. Conclusion: This study reveals that intralesional IFN α–2b injections have a significant benefit on penile hemodynamic parameters. Moreover, intralesional IFN α–2b is an effective, minimally invasive treatment for PD, and PDDU is a useful adjunct to monitor objectively changes in penile vascular parameters.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rosen, R. C., Riley, A., Wagner, G., Osterloh, I. H., Kirkpatrick, J., & Mishra, A. (1997) · Urology · doi:10.1016/s0090-4295(97)00238-0 · Cited by 5,849
Duncan, M. R., Berman, B., & Nseyo, U. O. (1991) · Scandinavian Journal of Urology and Nephrology · doi:10.3109/00365599109024539 · Cited by 132
Weidner, W., Schroeder-Printzen, I., Weiske, W.-H., & Vosshenrich, R. (1997) · Journal of Urology · doi:10.1016/s0022-5347(01)65370-9 · Cited by 121
Cited by
Peyronie’s Disease: AUA Guideline
Nehra, A., Alterowitz, R., Culkin, D. J., Faraday, M. M., Hakim, L. S., Heidelbaugh, J. J., Khera, M., Kirkby, E., McVary, K. T., Miner, M. M., et al. (2015) · Journal of Urology · doi:10.1016/j.juro.2015.05.098 · Cited by 416
Evidence-Based Management Guidelines on Peyronie's Disease
Chung, E., Ralph, D., Kagioglu, A., Garaffa, G., Shamsodini, A., Bivalacqua, T., Glina, S., Hakim, L., Sadeghi-Nejad, H., & Broderick, G. (2016) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2016.04.062 · Cited by 227
Peyronie’s disease: Contemporary evaluation and management
Ziegelmann, M. J., Bajic, P., & Levine, L. A. (2020) · International Journal of Urology · doi:10.1111/iju.14230 · Cited by 86
Peyronie’s disease: pharmacological treatments and limitations
Li, E. V., Esterquest, R., Pham, M. N., Panken, E. J., Amarasekera, C., Siebert, A., Bajic, P., & Levine, L. A. (2021) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2021.1903873 · Cited by 24
Non-surgical therapies for Peyronie’s disease
Rosenberg, J. E., Ergun, O., Hwang, E. C., Risk, M. C., Jung, J. H., Edwards, M. E., Blair, Y., & Dahm, P. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012206.pub2 · Cited by 14
Metadata
- Authors
- Kendirci, M., Usta, M. F., Matern, R. V., Nowfar, S., Sikka, S. C., & Hellstrom, W. J. G.
- Venue
- The Journal of Sexual Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-09-01
- Volume
- 2
- Issue
- 5
- Pages
- 709-715
- ISSN
- 1743-6095 (ISSN-L)
- 1743-6109
- OpenAlex
- W2008115305
- Cited by
- 68
- References
- 3
- FWCI
- 1.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Impact of Intralesional Interferon α–2b Injection Therapy on Penile Hemodynamics in Men with Peyronie’s Disease. https://app.cochat.ai/papers/10.1111/j.1743-6109.2005.00110.x
- The paper
- Kendirci, M., Usta, M. F., Matern, R. V., Nowfar, S., Sikka, S. C., & Hellstrom, W. J. G. (2005). The Impact of Intralesional Interferon α–2b Injection Therapy on Penile Hemodynamics in Men with Peyronie’s Disease. The Journal of Sexual Medicine. https://doi.org/10.1111/j.1743-6109.2005.00110.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.